Literature DB >> 27826871

Anti-N-methyl-D-aspartate receptor encephalitis after Herpes simplex virus-associated encephalitis: an emerging disease with diagnosis and therapeutic challenges.

Flora Schein1, Amandine Gagneux-Brunon2, Jean-Christophe Antoine1, Sylvie Lavernhe1, Sylvie Pillet1, Stéphane Paul1, Anne Frésard1, Claire Boutet1, Rémi Grange1, Céline Cazorla1, Frédéric Lucht1, Elisabeth Botelho-Nevers1.   

Abstract

INTRODUCTION: Morbidity and mortality of Herpes simplex virus encephalitis (HSE) remain high. Relapses of neurological signs may occur after initial clinical improvement under acyclovir treatment.
METHODS: We report here a case of post-HSE anti-N-methyl-d-aspartate receptor-mediated encephalitis in an adult and perform a systematic search on PubMed to identify other cases in adults.
RESULTS: We identified 11 previously published cases, to discuss diagnostic and therapeutic management. Symptoms in adults are often inappropriate behaviors, confusion and agitation. Diagnosis of anti-NMDA-R encephalitis after HSE is often delayed. Treatment consists in steroids, plasma exchange, and rituximab. Prognosis is often favorable.
CONCLUSION: Anti-NMDA-R antibodies should be searched in cerebrospinal fluid of patients with unexpected evolution of HSE. This emerging entity reopens the hot debate about steroids in HSE.

Entities:  

Keywords:  Anti-NMDA-receptor antibodies; Autoimmune encephalitis; Encephalitis; Herpes simplex virus; Neurological relapses

Mesh:

Substances:

Year:  2016        PMID: 27826871     DOI: 10.1007/s15010-016-0959-y

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

1.  Herpes simplex encephalitis relapses in children: differentiation of two neurologic entities.

Authors:  X De Tiège; F Rozenberg; V Des Portes; J B Lobut; P Lebon; G Ponsot; B Héron
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

2.  Development and Validation of a Laboratory-Developed Multiplex Real-Time PCR Assay on the BD Max System for Detection of Herpes Simplex Virus and Varicella-Zoster Virus DNA in Various Clinical Specimens.

Authors:  Sylvie Pillet; Paul O Verhoeven; Amélie Epercieux; Thomas Bourlet; Bruno Pozzetto
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

3.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

4.  Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir.

Authors:  Y Ito; H Kimura; Y Yabuta; Y Ando; T Murakami; M Shiomi; T Morishima
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

5.  HSV encephalitis-induced anti-NMDAR encephalitis in a 67-year-old woman: report of a case and review of the literature.

Authors:  Nicholas A Morris; Tamara B Kaplan; Jenny Linnoila; Tracey Cho
Journal:  J Neurovirol       Date:  2015-07-03       Impact factor: 2.643

6.  Herpes simplex virus encephalitis is a trigger of brain autoimmunity.

Authors:  Thaís Armangue; Frank Leypoldt; Ignacio Málaga; Miquel Raspall-Chaure; Itxaso Marti; Charles Nichter; John Pugh; Monica Vicente-Rasoamalala; Miguel Lafuente-Hidalgo; Alfons Macaya; Michael Ke; Maarten J Titulaer; Romana Höftberger; Heather Sheriff; Carol Glaser; Josep Dalmau
Journal:  Ann Neurol       Date:  2014-02-25       Impact factor: 10.422

7.  Autoimmune post-herpes simplex encephalitis of adults and teenagers.

Authors:  Thaís Armangue; Germán Moris; Verónica Cantarín-Extremera; Carlos Enrique Conde; Kevin Rostasy; Maria Elena Erro; Juan Carlos Portilla-Cuenca; Eulàlia Turón-Viñas; Ignacio Málaga; Beatriz Muñoz-Cabello; Carmen Torres-Torres; Sara Llufriu; Luis González-Gutiérrez-Solana; Guillermo González; Ignacio Casado-Naranjo; Myrna Rosenfeld; Francesc Graus; Josep Dalmau
Journal:  Neurology       Date:  2015-10-21       Impact factor: 9.910

8.  Infectious encephalitis in france in 2007: a national prospective study.

Authors:  Alexandra Mailles; Jean-Paul Stahl
Journal:  Clin Infect Dis       Date:  2009-12-15       Impact factor: 9.079

9.  N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis.

Authors:  Harald Prüss; Carsten Finke; Markus Höltje; Joerg Hofmann; Christine Klingbeil; Christian Probst; Kathrin Borowski; Gudrun Ahnert-Hilger; Lutz Harms; Jan M Schwab; Christoph J Ploner; Lars Komorowski; Winfried Stoecker; Josep Dalmau; Klaus-Peter Wandinger
Journal:  Ann Neurol       Date:  2012-12       Impact factor: 10.422

10.  Herpes simplex encephalitis as a potential cause of anti-N-methyl-D-aspartate receptor antibody encephalitis: report of 2 cases.

Authors:  Allen Desena; Donna Graves; Worthy Warnack; Benjamin M Greenberg
Journal:  JAMA Neurol       Date:  2014-03       Impact factor: 18.302

View more
  4 in total

1.  Anti-NMDA receptor encephalitis triggered by epilepsy surgery.

Authors:  Judith N Wagner; Gabriele Schwarz; Gertraud Puttinger; Anna Maria Hengsberger; Stefan Guggenberger; Serge Weis; Johannes Trenkler; Martin Aichholzer; Tim J von Oertzen
Journal:  J Neurol       Date:  2018-05-30       Impact factor: 4.849

2.  Anti-NMDAR Encephalitis Following Herpes Simplex Virus Encephalitis: 2 Cases From Portugal.

Authors:  Ana Brás; Ana André; Laura Sá; João Carvalho; Anabela Matos; Helena Gens; Hipólito Nzwalo
Journal:  Neurohospitalist       Date:  2019-08-26

Review 3.  Catatonia and the immune system: a review.

Authors:  Jonathan P Rogers; Thomas A Pollak; Graham Blackman; Anthony S David
Journal:  Lancet Psychiatry       Date:  2019-06-10       Impact factor: 77.056

Review 4.  Recurrent anti-NMDAR encephalitis during pregnancy combined with two antibodies positive.

Authors:  Hong Liu; Xiu Chen
Journal:  Arch Womens Ment Health       Date:  2021-04-09       Impact factor: 3.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.